NCT01049126View on ClinicalTrials.gov

Retrospective Case Study Examining Patient Outcomes Compared to the ChemoFx Assay in Endometrial Cancer Patients

CompletedOBSERVATIONAL
Enrollment

76

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

February 28, 2010

Conditions
Endometrial Cancer
Interventions
OTHER

ChemoFx

Chemoresponse Marker Assay

Trial Locations (1)

15203

Precision Therapeutics, Inc., Pittsburgh

Sponsors
All Listed Sponsors
lead

Precision Therapeutics

INDUSTRY